Find Clinical Trials

All CategoriesMedications / Interventions»Ii»Isotretinoin



Join Paid Clinical Trials



  • Condition:   Male Infertility, Azoospermia
    Intervention:   Drug: 13-cis retinoic acid
    Sponsor:   University of Washington
    Recruiting

  • Condition:   Neuroblastoma
    Interventions:   Biological: Hu3F8;   Drug: GM-CSF;   Drug: Isotretinoin
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Y-mAbs Therapeutics
    Recruiting

  • Condition:   Solid Tumor
    Interventions:   Drug: Cabozantinib;   Drug: 13-cis-retinoic acid
    Sponsors:   Peter Zage;   Exelixis
    Recruiting

  • Condition:   Acne Vulgaris
    Interventions:   Drug: Tretinoin;   Drug: Isotretinoin
    Sponsor:   University of California, Davis
    Recruiting

  • Condition:   Contraception
    Intervention:  
    Sponsors:   University of Colorado, Denver;   Society of Family Planning
    Recruiting

  • Condition:   Neuroblastoma
    Interventions:   Drug: Carboplatin;   Biological: Autologous stem cell infusion;   Biological: Granulocyte colony stimulating factor;   Radiation: Radiation therapy;   Drug: Isotretinoin (13-cis-retinoic acid);   Drug: Melphalan;   Drug: Etoposide
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Recruiting

  • Condition:   Neuroblastoma
    Interventions:   Drug: cyclophosphamide;   Drug: topotecan;   Biological: hu14.18K322A;   Procedure: peripheral blood stem cell harvest;   Procedure: surgical resection;   Drug: cisplatin;   Drug: etoposide;   Drug: doxorubicin;   Drug: vincristine;   Drug: busulfan;   Drug: melphalan;   Biological: peripheral blood stem cell transplantation;   Biological: natural killer cell infusion;   Radiation: radiation therapy;   Biological: GM-CSF;   Biological: G-CSF;   Drug: mesna;   Drug: levetiracetam;   Biological: interleukin-2;   Drug: Isotretinoin;   Device: CliniMACS
    Sponsors:   St. Jude Children's Research Hospital;   Cookies for Kids' Cancer;   CURE Childhood Cancer, Inc.
    Recruiting

  • Condition:   Psoriasis
    Intervention:   Other: Fasting blood draw for lipid assessments
    Sponsors:   Northwestern University;   National Psoriasis Foundation;   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting

  • Conditions:   Ganglioneuroblastoma;   High-Risk Neuroblastoma;   NMYC Gene Amplification
    Interventions:   Biological: Aldesleukin;   Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Dexrazoxane;   Biological: Dinutuximab;   Drug: Doxorubicin;   Drug: Etoposide;   Radiation: External Beam Radiation Therapy;   Drug: Isotretinoin;   Drug: Melphalan;   Biological: Sargramostim;   Drug: Thiotepa;   Drug: Topotecan;   Drug: Vincristine
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Childhood Ganglioneuroblastoma;   Childhood Neuroblastoma;   INRG Stage L2;   INRG Stage M;   INRG Stage MS;   NMYC Gene Amplification;   Recurrent Neuroblastoma
    Interventions:   Biological: Aldesleukin;   Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Busulfan;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Crizotinib;   Drug: Cyclophosphamide;   Drug: Dexrazoxane Hydrochloride;   Biological: Dinutuximab;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide Phosphate;   Radiation: External Beam Radiation Therapy;   Radiation: Iobenguane I-131;   Drug: Isotretinoin;   Other: Laboratory Biomarker Analysis;   Drug: Melphalan;   Other: Pharmacological Study;   Biological: Sargramostim;   Procedure: Therapeutic Conventional Surgery;   Drug: Thiotepa;   Drug: Topotecan Hydrochloride;   Drug: Vincristine Sulfate
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting

Login to Get Started